Incidence, Risk Factors, and Outcomes of Pouchitis and Pouch-Related Complications in Patients With Ulcerative Colitis

被引:72
作者
Barnes, Edward L. [1 ,2 ,3 ]
Herfarth, Hans H. [1 ,2 ,3 ]
Kappelman, Michael D. [2 ,4 ]
Zhang, Xian [3 ]
Lightner, Amy [5 ]
Long, Millie D. [1 ,2 ,3 ]
Sandler, Robert S. [1 ,3 ]
机构
[1] Univ N Carolina, Div Gastroenterol & Hepatol, Campus Box 7080,130 Mason Farm Rd, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Multidisciplinary Ctr Inflammatory Bowel Dis, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA
[4] Univ N Carolina, Div Pediat Gastroenterol, Chapel Hill, NC 27515 USA
[5] Cleveland Clin, Lerner Coll Med, Digest Dis & Surg Inst, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Hospitalization; Antibiotics; Utilization; Inflammation; ANAL ANASTOMOSIS; RESTORATIVE PROCTOCOLECTOMY; CROHNS-DISEASE; METAANALYSIS;
D O I
10.1016/j.cgh.2020.06.035
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Acute pouchitis is the most common non-surgical complication after restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC). We used validated case-finding definitions for pouchitis to search administrative claims data and determine the incidence of pouchitis in the first 2 years after IPAA. METHODS: We identified all patients who underwent proctocolectomy with IPAA for UC in the IQVIA Legacy PharMetrics Adjudicated Claims Database, from January 1, 2007 through June 1, 2016. The primary outcome was the development of pouchitis within 2 years after IPAA. Secondary outcomes included isolated acute vs recurrent pouchitis, immunosuppressive therapy, further surgery, and admission to the hospital. RESULTS: Among 594 patients, the cumulative incidence of pouchitis within 2 years of IPAA was 48% (95% CI, 44%-52%). The cumulative incidence of isolated acute pouchitis was 29% (95% CI, 26%-33%). Compared to patients with isolated acute pouchitis, patients who received a diagnosis of recurrent pouchitis (cumulative incidence, 19%: 95% CI, 16%-22%) demonstrated increased outpatient visits, emergency department visits, and inpatient admissions (all P < .001). Patients who developed pouchitis were more likely to have a history of primary sclerosing cholangitis (adjusted odds ratio [aOR], 3.94; 95% CI, 1.05-14.8) and anti-tumor necrosis factor alpha therapy prior to colectomy (aOR 1.63; 95% CI, 1.09-2.45). Among patients with pouchitis, the cumulative frequency of new immunosuppressive therapy was 40% (95% CI, 35%-46%) and the cumulative incidence of pouch excision was 1.0% (95% CI, 0.4%-3.0%). The cumulative incidence of a new diagnosis of Crohn's disease after IPAA for UC was 9.0% (95% CI, 7.2%-11%). CONCLUSIONS: In a geographically diverse population, 48% of patients with UC developed pouchitis within the first 2 years after IPAA. Patients with pouchitis had greater use of healthcare resources, indicating a significant burden of disease.
引用
收藏
页码:1583 / +
页数:13
相关论文
共 27 条
[1]  
Bar N, 2018, GASTROENTEROLOGY, V154, pS28
[2]   Perioperative and Postoperative Management of Patients With Crohn's Disease and Ulcerative Colitis [J].
Barne, Edward L. ;
Lightner, Amy L. ;
Regueiro, Miguel .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) :1356-1366
[3]   The Incidence and Definition of Crohn's Disease of the Pouch: A Systematic Review and Meta-analysis [J].
Barnes, Edward L. ;
Kochar, Bharati ;
Jessup, Hilary R. ;
Herfarth, Hans H. .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (09) :1474-1480
[4]   Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis [J].
Barnes, Edward L. ;
Herfarth, Hans H. ;
Sandler, Robert S. ;
Chen, Wenli ;
Jaeger, Elizabeth ;
Nguyen, Van M. ;
Robb, Amber R. ;
Kappelman, Michael D. ;
Martin, Christopher F. ;
Long, Millie D. .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) :1218-1224
[5]  
Barnes EL, 2020, CLIN GASTROENTEROL H
[6]  
Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735
[7]   Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data [J].
Coward, Stephanie ;
Clement, Fiona ;
Benchimol, Eric I. ;
Bernstein, Charles N. ;
Avina-Zubieta, J. Antonio ;
Bitton, Alain ;
Carroll, Mathew W. ;
Hazlewood, Glen ;
Jacobson, Kevan ;
Jelinski, Susan ;
Deardon, Rob ;
Jones, Jennifer L. ;
Kuenzig, M. Ellen ;
Leddin, Desmond ;
McBrien, Kerry A. ;
Murthy, Sanjay K. ;
Nguyen, Geoffrey C. ;
Otley, Anthony R. ;
Panaccione, Remo ;
Rezaie, Ali ;
Rosenfeld, Greg ;
Pena-Sanchez, Juan Nicolas ;
Singh, Harminder ;
Targownik, Laura E. ;
Kaplan, Gilaad G. .
GASTROENTEROLOGY, 2019, 156 (05) :1345-+
[8]   Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy [J].
Dubinsky, Vadim ;
Reshef, Leah ;
Bar, Nir ;
Keizer, Danielle ;
Golan, Noam ;
Rabinowitz, Keren ;
Godny, Lihi ;
Yadgar, Karin ;
Zonensain, Keren ;
Tulchinsky, Hagit ;
Gophna, Uri ;
Dotan, Iris .
GASTROENTEROLOGY, 2020, 158 (03) :610-+
[9]   Ileal Pouch Anal Anastomosis Analysis of Outcome and Quality of Life in 3707 Patients [J].
Fazio, Victor Warren ;
Kiran, Ravi P. ;
Remzi, Feza H. ;
Coffey, John Calvin ;
Heneghan, Helen Mary ;
Kirat, Hasan Tarik ;
Manilich, Elena ;
Shen, Bo ;
Martin, Sean T. .
ANNALS OF SURGERY, 2013, 257 (04) :679-685
[10]   Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after heal pouch-anal anastomosis [J].
Fleshner, Phillip ;
Ippoliti, Andrew ;
Dubinsky, Marla ;
Vasiliauskas, Eric ;
Mei, Ling ;
Papadakis, Konstantinos A. ;
Rotter, Jerome I. ;
Landers, Carol ;
Targan, Stephan .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (05) :561-568